RBC Bearings: Great Company, Ugly Chart, and the Gap Between the Two Is the Whole Trade

# RBC Bearings: Great Company, Ugly Chart, and the Gap Between the Two Is the Whole Trade

Here's a fun exercise: find me another industrial name that just printed 18% revenue growth, expanded gross margins to nearly 45%, put up a record free-cash-flow quarter, and got rewarded by the market with a 25% haircut from its 52-week high. That's RBC Bearings right now — a business firing on every cylinder that fundamentals-watchers care about, wearing a chart that technicians want nothing to do with. Both camps are right. That's what makes this interesting.

The Numbers Don't Lie

Let's start with what actually happened, because it's genuinely good. RBC's Q4 FY2026 print, out in mid-May, showed adjusted diluted EPS of $3.62 — a beat of roughly 9% — on revenue of about $518M, up 18.3% year-over-year, with gross margin at 44.4%. GAAP EPS came in at $2.89 versus $2.30 a year prior. Full-year EPS landed at $9.14, up from $7.76 in FY2025. Adjusted EBITDA got raised to $605.3M, backlog swelled to $2.3B, and management guided Q1 FY2027 sales to $500–$510M. Free cash flow hit a record $146.9M in the most recent quarter alone, with TTM free cash flow around $283M. The balance sheet is getting cleaner too — total debt down from $1.13B to $878M in nine months, debt-to-equity now a tidy 0.25.

This is a company riding the aerospace and defense supercycle, doing small accretive bolt-ons (the $24.2M PSC Couplings deal extends the Dodge coupling franchise) rather than swinging for the fences, and generating the kind of operating leverage — margins expanding from 22.5% to 27.1% over four quarters — that makes quality-screen algorithms swoon. One valuation service pegs it a 9.5/10 on quality. No argument here.

So Why Is the Stock Down 13% in a Month?

Because none of that matters if you already paid for it. And investors paid up for RBC in a big way. The stock ran from roughly $455 in September last year to $660 by late June, and has since round-tripped back down to the $500 handle — a clean lower-highs, lower-lows breakdown on the daily chart. It's sitting 7% below its 20-day moving average, 13% below the 50-day, and nearly 8% below the 200-day. Six-month performance versus the S&P is ugly: 3.4% for RBC against 10.9% for SPY. RSI at 31.6 is knocking on oversold's door.

Here's the tell, though: there's no negative fundamental catalyst behind this selloff. No guidance cut, no lost contract, no accounting scare. This reads like plain old multiple compression — a stock that ran too far, too fast, on a trailing P/E north of 49x, now digesting that move while the market rotates away from anything priced for perfection. One valuation screen found zero of ten models showing upside at the ~$572 level it was tested at. That's a flashing caution light on price, not on the business.

Where the Trade Actually Sits

Strip out the noise and you get a forward P/E around 30 — still not "cheap," but a lot more defensible than trailing 49x, especially against an EV/EBITDA of 26.6 for a business compounding free cash flow and delevering simultaneously. The $500 level is both psychologically loaded and sitting near daily support; a decisive break below $475 would be the signal that this is more than a digestion phase and opens the door toward $455, last September's pivot. On the upside, $525–540 is the first mean-reversion target — basically filling back to the 20/50-day averages — with $575 as the level that would say the downtrend is actually broken.

The next real catalyst is the Q1 FY2027 print, expected around October 30 — roughly two months out from today. Between now and then, this is a stock without a fresh story, just a market deciding how much it's willing to pay for one it already knows.

The Take

RBC isn't broken — the stock's momentum is. Backlog is at record levels, margins are still expanding, free cash flow is compounding, and the balance sheet is getting tighter every quarter. That's not a value trap dressed up as quality; it's quality that got too popular for its own good and is now paying the multiple-compression tax. The setup favors patient accumulation into weakness near $495–505, sized modestly until the downtrend actually breaks, rather than either chasing the "everything's fine" bull case at $650 or panicking out at $500 because the chart looks scary. Great businesses occasionally go on sale because the crowd forgot the difference between a stock and a company. This might be one of those moments — just don't confuse "on sale" with "cheap."